The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Tissue Heart Valves Market During 2026–2030?
The market size for tissue heart valves has experienced consistent growth in recent years. Its value is projected to rise from $1.52 billion in 2025 to $1.56 billion in 2026, at a compound annual growth rate (CAGR) of 2.6%. This historical expansion can be primarily attributed to factors such as the increasing incidence of cardiovascular diseases, the limitations associated with mechanical valves, the growing adoption of surgical valve replacement procedures, improvements in hospital cardiac infrastructure, and an aging demographic.
The tissue heart valves market size is anticipated to experience steady expansion over the coming years. It is projected to grow to $1.72 billion in 2030, achieving a compound annual growth rate (CAGR) of 2.5%. This growth in the forecast period can be attributed to several factors, including the increased adoption of TAVR procedures, the rise in minimally invasive cardiac surgeries, innovations leading to longer valve durability, enhanced healthcare access, and the expansion of cardiology specialization. Prominent trends for this period include a greater preference for bioprosthetic valves, an increase in transcatheter valve procedures, advancements in tissue preservation techniques, a reduced need for long-term anticoagulation, and the demand for valve replacement driven by an aging population.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp
What Drivers Are Expected To Influence The Tissue Heart Valves Market During The Forecast Period?
The rising occurrence of cardiovascular ailments is anticipated to drive expansion in the tissue heart valves market in the coming period. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as heart attacks, strokes, and high blood pressure. The growing incidence of CVDs stems mainly from elements like unhealthy habits, older demographics, a rise in risk factors, inadequate nutrition, sedentary living, tobacco use, stress, and urban development, resulting in a global surge in heart-related conditions. Tissue heart valves play a vital role in managing CVDs, offering a biocompatible, long-lasting, and less clot-forming alternative for patients needing valve replacement, thereby enhancing sustained heart performance and lowering complication risks. As an illustration, a report released in September 2024 by the Heart Failure Society of America (HFSA), a US-based professional organization, stated that around 6.7 million Americans aged 20 and above currently suffer from heart failure (HF). This figure is projected to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Consequently, the expanding occurrence of cardiovascular diseases fuels the expansion of the tissue heart valve market.
How Are The Various Segments Of The Tissue Heart Valves Market Categorized?
The tissue heart valves market covered in this report is segmented –
1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves
2) By Procedure Type: Surgical Aortic Valve Replacement (SAVR), Transcatheter Aortic Valve Replacement (TAVR)
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves
2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves
What Trends Are Affecting The Expansion Of The Tissue Heart Valves Market?
Leading companies in the tissue heart valves market are concentrating on developing innovative products, such as surgical aortic tissue valves, to simplify their use during implantation and throughout a patient’s lifetime management. A surgical aortic tissue valve is a prosthetic heart valve crafted from biological tissue, typically utilized to replace a diseased or damaged aortic valve in cardiac surgery. For instance, in June 2024, Medtronic plc., an Ireland-based technology company, launched the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to enhance ease of use during implantation and support long-term patient management. Building on 10 years of clinical experience with the Avalus valve, it features a low valve profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) for improved blood flow. The valve also incorporates a radiopaque coil for clear visibility in future valve-in-valve procedures, providing long-term durability for patients with aortic stenosis.
Which Major Firms Influence Developments In The Tissue Heart Valves Market?
Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, St. Jude Medical Inc., Sorin Group, Hancock J & Co.
Read the full tissue heart valves market report here:
https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report
Which Region Is Forecast To Lead The Tissue Heart Valves Market In Terms Of Market Size?
North America was the largest region in the tissue heart valves market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Tissue Heart Valves Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=21302&type=smp
Browse Through More Reports Similar to the Global Tissue Heart Valves Market 2026, By The Business Research Company
Prosthetic Heart Valve Devices And Equipment Market Report 2026
Pediatric Heart Valve Repair And Replacement Market Report 2026
Commercial Valves Market Report 2026
https://www.thebusinessresearchcompany.com/report/commercial-valves-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model